June 12, 2017 - By wolcottdaily
Augustine Asset Management Inc increased Merck & Co (Mrk) (MRK) stake by 33.25% reported in 2016Q4 SEC filing. Augustine Asset Management Inc acquired 20,982 shares as Merck & Co (Mrk) (MRK)’s stock declined 2.46%. The Augustine Asset Management Inc holds 84,086 shares with $4.95M value, up from 63,104 last quarter. Merck & Co (Mrk) now has $179.43B valuation. The stock decreased 0.02% or $0.01 during the last trading session, reaching $64.39. About shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since June 12, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.
Atomera (NASDAQ:ATOM) had a decrease of 22.62% in short interest. ATOM’s SI was 47,900 shares in June as released by FINRA. Its down 22.62% from 61,900 shares previously. With 21,500 avg volume, 2 days are for Atomera (NASDAQ:ATOM)’s short sellers to cover ATOM’s short positions. The SI to Atomera’s float is 0.54%. The stock increased 1.90% or $0.08 on June 9, reaching $4.28. About shares traded. Atomera Inc (NASDAQ:ATOM) has 0.00% since June 12, 2016 and is . It has underperformed by 16.70% the S&P500.
Augustine Asset Management Inc decreased Intl Business Machines (Ibm) (NYSE:IBM) stake by 3,100 shares to 63,584 valued at $10.55M in 2016Q4. It also reduced Taiwan Semiconductor (Tsm) (NYSE:TSM) stake by 24,113 shares and now owns 166,654 shares. Magna Intl (Mga) (NYSE:MGA) was reduced too.
Among 17 analysts covering Merck & Co. Inc. (NYSE:MRK), 12 have Buy rating, 1 Sell and 4 Hold. Therefore 71% are positive. Merck & Co. Inc. had 36 analyst reports since August 13, 2015 according to SRatingsIntel. Morgan Stanley upgraded the stock to “Overweight” rating in Thursday, January 12 report. UBS maintained Merck & Co., Inc. (NYSE:MRK) on Friday, August 19 with “Buy” rating. The stock has “Outperform” rating by BMO Capital Markets on Thursday, August 13. The stock has “Hold” rating by Jefferies on Friday, April 15. The rating was maintained by Credit Suisse on Monday, May 9 with “Neutral”. The stock has “Buy” rating by Bryan Garnier & Cie on Friday, January 13. The rating was initiated by Societe Generale on Wednesday, September 30 with “Hold”. The firm has “Buy” rating given on Tuesday, November 24 by Berenberg. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) on Tuesday, June 14 with “Hold” rating. The rating was downgraded by BMO Capital Markets on Monday, July 18 to “Market Perform”.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.